ABMD - Johnson & Johnson said to have approached Abiomed
- Johnson & Johnson ( NYSE: JNJ ) is said to have approached Abiomed ( NASDAQ: ABMD ) about a transaction before a deal was eventually struck.
- Johnson ( JNJ ) reached out to Abiomed ( ABMD ) to start deal talks, according to CNBC's David Faber. Abiomed shares jumped 50% on the deal.
- Earlier Wednesday Johnson & Johnson ( JNJ ) has agreed to acquire cardiac pump maker Abiomed, Inc. for an upfront payment of $380.00 per share in cash, in addition to a CVR under which they can receive up to $35.00 per share in cash if certain milestones are reached.
For further details see:
Johnson & Johnson said to have approached Abiomed